BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 7, 2019
View Archived Issues
Novel selective PI3Kgamma inhibitors induce specific conformational changes
Read More
Myelin from hair stem cells
Read More
Small-molecule HDAC6 inhibitor improves memory and learning in fragile X syndrome in vivo
Read More
Orally active small molecule against influenza A hemagglutinin mimicking a broadly neutralizing Ab
Read More
AlzeCure redirects development of ACD-855 from cognition to eye indication
Read More
By itself, GITR stimulation can't "GIT'R done"
Read More
Targeting metabolism prevents epilepsy after TBI
Read More
KalVista presents data on PKa inhibitors for retinal edema
Read More
Antitumor activity of IC9-Luc90-CD828Z demonstrated in vitro
Read More
Huntington's hopefuls present at AAN 2019
Read More
FDA clears OnKure's IND to initiate phase I studies of OKI-179
Read More
Daewoong Pharmaceutical patents BTK and ITK dual inhibitors
Read More
Adaptimmune announces clinical progress with ADP-A2M4 in synovial sarcoma and other solid tumors
Read More
FDA approves Vyndaqel and Vyndamax for the treatment of cardiomyopathy caused by ATTR-CM
Read More
Gilead Sciences divulges new HIV protease inhibitors
Read More
Esteve Pharmaceuticals presents new analgesics
Read More
Shanghai Longwood Biopharmaceuticals identifies PD-1/PD-L1 inhibitors
Read More
Skyhawk and Takeda collaborate to develop small-molecule treatments for neurodegenerative diseases
Read More
European Commission approves Palynziq to treat PKU
Read More
Sunshine Lake Pharma divulges compounds for HBV infections
Read More
Onxeo treats first patient in phase Ib study of AsiDNA for solid tumors
Read More
Verona initiates phase IIb study of nebulized ensifentrine in moderate to severe COPD
Read More
DSMB recommends continuation of phase I/II PIONEER study of GS-030 in retinitis pigmentosa
Read More
Axsome announces expedited development and pivotal status for AXS-05 for the treatment of MDD
Read More
First patient dosed in phase I DUET-3 study of XmAb-23104
Read More
Phase III trial of Epidiolex in TSC meets primary endpoint
Read More
CytoDyn reports data from leronlimab monotherapy study
Read More
Simple, reversible mouse model mimics secondary glaucoma
Read More
FDA approves Ruzurgi for pediatric patients with Lambert-Eaton myasthenic syndrome
Read More